|
AFTPH expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.40949515684497E-11 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.42669994999068E-09 |
| Normal-vs-Stage2 |
2.46569999995394E-06 |
| Normal-vs-Stage3 |
1.0972001085463E-10 |
| Normal-vs-Stage4 |
6.91680002162798E-09 |
| Stage1-vs-Stage2 |
6.928600E-01 |
| Stage1-vs-Stage3 |
7.571600E-02 |
| Stage1-vs-Stage4 |
1.512590E-01 |
| Stage2-vs-Stage3 |
4.079800E-01 |
| Stage2-vs-Stage4 |
4.269600E-01 |
| Stage3-vs-Stage4 |
9.361200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.76340053670287E-11 |
| Normal-vs-AfricanAmerican |
1.939870E-03 |
| Normal-vs-Asian |
4.78479999954651E-07 |
| Caucasian-vs-AfricanAmerican |
2.698200E-01 |
| Caucasian-vs-Asian |
6.058000E-01 |
| AfricanAmerican-vs-Asian |
5.101800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.83569945302986E-10 |
| Normal-vs-Female |
6.86450007947315E-10 |
| Male-vs-Female |
3.177000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.67720000005178E-08 |
| Normal-vs-Age(41-60Yrs) |
7.04969971287994E-10 |
| Normal-vs-Age(61-80Yrs) |
2.24899998624295E-09 |
| Normal-vs-Age(81-100Yrs) |
2.176800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.476600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.987000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.494800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.750200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.260200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.490200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.488200E-02 |
| Classical-VS-Follicular |
4.356800E-01 |
| Classical-VS-Other |
2.973200E-01 |
| Classical-VS-Normal |
4.78869999209763E-09 |
| Tall-VS-Follicular |
2.444600E-01 |
| Tall-VS-Other |
8.893000E-01 |
| Tall-VS-Normal |
7.73199999581919E-08 |
| Follicular-VS-Other |
5.317400E-01 |
| Follicular-VS-Normal |
5.40159999951051E-07 |
| Other-VS-Normal |
2.176600E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.11370002109368E-09 |
| Normal-vs-N1 |
3.51599971359917E-10 |
| N0-vs-N1 |
1.449590E-01 |
|
|
